Sampling-Based Approach to Determining Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Scale-Up Programs in Africa
Authors:
- Elvin H. GengEGElvin H. Geng
- Nneka EmenyonuNENneka Emenyonu
- Mwebesa Bosco BwanaMBMwebesa Bosco Bwana
- David V. GliddenDGDavid V. Glidden
- Jeffrey N. MartinJMJeffrey N. Martin
Open Access
- 6 August 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (5) , 506-507
Abstract
To the Editor: Evaluating outcomes among the millions of HIV-infected patients starting antiretroviral therapy (ART) in settings with limited resources is key to understanding the effect of current treatment programs and guiding future strategies. Accurately assessing survival outcomes has been precluded by substantial numbers of patients not returning for care. One year after starting ART, 15% to 30% of patients are lost to follow-up.1,2 Only by determining the outcomes of those lost can true survival and program impact be understood. We present a sampling-based strategy to address this.Keywords
This publication has 3 references indexed in Scilit:
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2007
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- Addressing an Idiosyncrasy in Estimating Survival Curves Using Double Sampling in the Presence of Self‐Selected Right CensoringBiometrics, 2001